After this article [1] was published, the corresponding author informed the journal of an omission in the Competing Interests statement. Based on information gathered in editorial follow-up, the corrected Competing Interests statement is: LMK invented the DNAzyme Dz13 and is listed as an inventor on patent application US 10/923197, owned by NewSouth Innovations Pty Ltd, the Technology Transfer and Innovation Office of UNSW Australia (The University of New South Wales). This does not alter our adherence to PLOS One policies on sharing data and materials.
Reference
Citation: Chan CWS, Kaplan W, Parish CR, Khachigian LM (2026) Correction: Reduced Retinal Microvascular Density, Improved Forepaw Reach, Comparative Microarray and Gene Set Enrichment Analysis with c-jun Targeting DNA Enzyme. PLoS One 21(5): e0349921. https://doi.org/10.1371/journal.pone.0349921
Published: May 26, 2026
Copyright: © 2026 Chan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.